Green Valley Drugs Recalls Methylprednisolone Acetate Injection Due to Sterility Concerns
Green Valley Drugs is recalling Methylprednisolone Acetate Injection products because the company could not ensure the sterility of the compounded and repackaged items.
What this means for you
Illness, injury, or structural failure has been reported. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: The recall is classified as FDA Class II and involves a lack of sterility assurance for injectable drugs, which poses a significant risk of serious health consequences such as infection.
Plain-English summary
FVS Holdings, Inc. dba. Green Valley Drugs is recalling Methylprednisolone Acetate Injection, including all strengths and presentations such as 40 mg/mL and 80 mg/mL vials and syringes. The recall involves 4,350 units distributed nationwide.
The recall was initiated due to a lack of assurance of sterility. The source text indicates that all sterile products compounded, repackaged, and distributed by this compounding pharmacy are affected due to concerns associated with the quality control processes.
Consumers and healthcare providers should stop using the affected products and contact their pharmacist or the recalling firm for further instructions. The FDA has classified this recall as Class II.
The recalled product
- Product
- Methylprednisolone Acetate Injection, all strengths and all presentations including a) Methylprednisolone Acetate 40 mg/mL, b) Methylprednisolone Acetate (PF) 40 mg/mL, c) Methylprednisolone Acetate (PF) 80 mg/mL, d) Methylpred Acetate 40 mg/mL 1 mL, e) Methylprednisolone 80 mg/5
- Manufacturer
- FVS Holdings, Inc. dba. Green Valley Drugs
- Category
- Drug — Injectable Steroids
- Affected units
- 4,350
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (20)
- a) Methylprednisolone Acetate 40 mg/mL: 20130228-E
- Exp 5/28/2013
- 2013012370-GV3
- Exp 4/23/2013
- 20130318-D
- Exp 6/18/2013
- b) Methylprednisolone Acetate (PF) 40 mg/mL: 20130219-B
- Exp 5/19/2013
- 20130315-B
- Exp 6/15/2013
- c) Methylprednisolone Acetate (PF) 80 mg/mL: 201303131-A
- Exp 6/13/2013
- 20130304-M
- Exp 6/4/2013
- 20130405-A
- Exp 7/5/2013
- 20130214-G
- Exp 5/14/2013
- d) Methylpred Acetate 40 mg/mL 1 mL: 20130318-D
- e) Methylprednisolone 80 mg/5 mL: 20130214-G
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 78 recalled by FVS Holdings, Inc. dba. Green Valley Drugs under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 78 products in this recall →Related recalls
Same manufacturer · FVS Holdings, Inc. dba. Green Valley Drugs
See all →- SevereGreen Valley Drugs Recalls Alpha Lipoic Acid Injection Due to Sterility Concerns
FDA (Drugs) · 2013-05-22
- SevereGreen Valley Drugs Recalls Phosphatidylcholine Injection Due to Sterility Concerns
FDA (Drugs) · 2013-05-22
- SevereFDA Recalls Acetylcysteine Injection Due to Sterility Assurance Concerns
FDA (Drugs) · 2013-05-22
- SevereGreen Valley Drugs Recalls Thiamine Hydrochloride Injection Due to Sterility Concerns
FDA (Drugs) · 2013-05-22
- SevereGreen Valley Drugs Recalls Folic Acid Injections Due to Sterility Concerns
FDA (Drugs) · 2013-05-22
Same hazard · sterility failure
See all →- SevereROHTO DIGI-EYE Eye Drops Recalled Over Sterility Assurance Gap
FDA (Drugs) · 2026-07-29
- HighROHTO DRY-AID Eye Drops Recalled Due to Sterility Concerns
FDA (Drugs) · 2026-07-29
- SevereTransvenous Pacing Electrode Tray with Bipolar Balloon Pacing Electrode Recalled
FDA (Devices) · 2026-07-22
- SevereArterial Line Kit with Lidocaine HCL Injection Fails Sterility Testing
FDA (Devices) · 2026-07-22
- SevereOne-Piece Introducer Tray kits recalled for sterility failure
FDA (Devices) · 2026-07-22